Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland

Development

Volumn 129, Issue 17, 2002, Pages 4159-4170

  Li, Gang ^a   Robinson, Gertraud W ^a   Lesche, Ralf ^a   Martinez Diaz, Hilda ^a   Jiang, Zhaorong ^a   Rozengurt, Nora ^a   Wagner, Kay Uwe ^a   Wu, De Chang ^a   Lane, Timothy F ^a   Liu, Xin ^a   Hennighausen, Lothar ^a   Wu, Hong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cowden's disease; Ductal growth; Mammary development; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; BREAST HYPERTROPHY; CANCER RISK; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE DELETION; GENE LOSS; GENE MUTATION; GENETIC REGULATION; INHERITANCE; INVOLUTION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; STROMA; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; GENE DELETION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0036714806     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Delayed mammary gland involution in MMTV-AKT1 transgenic mice
2. Gatekeeper for endometrium: The PTEN tumor suppressor gene
3. Oncogenic kinase signalling
4. Regulation of cell death protease caspase-9 by phosphorylation
5. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis
6. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3
7. PTEN, a unique tumor suppressor gene
8. Cellular survival: A play in three Akts
9. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
10. Knockout mouse models and mammary tumorigenesis
11. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer
12. Pten is essential for embryonic development and tumour suppression
13. Mammary ductal and alveolar development: Lesson learned from genetically manipulated mice
14. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma
15. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype
16. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo
17. Signaling pathways in mammary gland development
18. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
19. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD
20. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association
21. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene
22. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
23. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
24. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice
25. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
26. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac 1 and Cdc42 GTPases
27. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation
28. Stat5a is mandatory for adult mammary gland development and lactogenesis
29. Cowden's disease: A possible new symptom complex with multiple system involvement
30. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
31. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome
32. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium
33. Introduction: Signaling in mammary development and tumorigenesis
34. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
35. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
36. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast
37. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
38. Stem cells, cancer, and cancer stem cells
39. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation
40. Clinical and pathological features of breast disease in Cowden's syndrome: An underrecognized syndrome with an increased risk of breast cancer
41. Mammary gland involution is delayed by activated Akt in transgenic mice
42. Mammary epithelial stem cells
43. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
44. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice
45. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
46. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathway
47. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
48. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
49. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice